Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
A. C. Herington, I. Mertens-Walker, J. E. Lisle, M. Maharaj & S.-A. Stephenson. (2014) Inhibiting Eph kinase activity may not be “Eph”ective for cancer treatment. Growth Factors 32:6, pages 207-213.
Read now
Read now
Articles from other publishers (3)
Saige M. Mitchell, Ryan M. Heise, Molly E. Murray, Dominic J. Lambo, Rachel E. Daso & Ipsita A. Banerjee. (2023) An investigation of binding interactions of tumor-targeted peptide conjugated polyphenols with the kinase domain of ephrin B4 and B2 receptors. Molecular Diversity.
Crossref
Crossref
Neeraj Kulkarni, Suchita Dattatray Shinde, Govinda Shivaji Jadhav, Diksha Ramesh Adsare, Kamya Rao, Mihir Kachhia, Mohit Maingle, Shubham Prakash Patil, Neha Arya & Bichismita Sahu. (2021) Peptide-Chitosan Engineered Scaffolds for Biomedical Applications. Bioconjugate Chemistry 32:3, pages 448-465.
Crossref
Crossref
Guru Karthikeyan Thirunavukkarasu, Kondareddy Cherukula, Hwangjae Lee, Yong Yeon Jeong, In-Kyu Park & Jae Young Lee. (2018) Magnetic field-inducible drug-eluting nanoparticles for image-guided thermo-chemotherapy. Biomaterials 180, pages 240-252.
Crossref
Crossref